Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions

European Heart Journal

Volumn 25, Issue 1, 2004, Pages 32-38

  Degertekin, Muzaffer ^a   Lemos, Pedro A ^a   Lee, Chi Hang ^a   Tanabe, Kengo ^a   Sousa, J Eduardo ^b   Abizaid, Alexandre ^b   Regar, Evelyn ^a   Sianos, George ^a   Van Der Giessen, Willem J ^a   De Feyter, Pim J ^a   Wuelfert, Egon ^c   Popma, Jeffrey J ^d   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c Cordis Corporation Brussels ^*  (Belgium)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Restenosis; Sirolimus; Stent; Ultrasound

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; VOLUMETRY;

CORONARY RESTENOSIS; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SIROLIMUS; STENTS;

EID: 9144222751     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.10.012     Document Type: Article

References (36)

1. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group [see comments]. N Engl J Med 1994;331:489-95.
2. Mudra H, Regar E, Klauss V et al. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. Circulation 1997;95:363-70.
3. Mehran R, Dangas G, Abizaid AS et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8.
4. Waksman R, White RL, Chan RC et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-71.
5. Teirstein PS, Massullo V, Jani S et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial [see comments]. Circulation 2000;101:360-5.
6. Leon MB, Teirstein PS, Moses JW et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6.
7. Directive 96/29/Euratom. Official Journal L;159:1-114.
8. Kay IP, Sabate M, Van Langenhove G et al. Outcome from balloon induced coronary artery dissection after intracoronary beta radiation. Heart 2000;83:332-7.
9. Albiero R, Nishida T, Adamian M et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 2000;101:2454-7.
10. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
11. Sousa JE, Costa MA, Abizaid AC et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104:2007-11.
12. Sousa JE, Costa MA, Abizaid A et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-7.
13. Degertekin M, Regar E, Tanabe K et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. The first clinical experience. J Am Coll Cardiol 2003;41:184-9.
14. Glover C, Ma X, Chen YX et al. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 2002;144:702-9.
15. Strauss BH, Chisholm RJ, Keeley FW et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
16. Koyama H, Reidy MA. Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. Circ Res 1998;82:988-95.
17. Koyama H, Reidy MA. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res 1997;80:408-17.
18. Rensing BJ, Vos J, Smits PC et al. Coronary restenosis elimination with a sirolimus eluting stent. First European human experience with six month angiographic and intravascular ultrasonic follow-up. Eur Heart J 2001;22:2125-30.
19. Hamers R BN, Knook M, Roelandt JRTC. A novel approach to quantitative analysis of intravascular Ultrasound Images. Computers in Cardiology 2001;28:589-92.
20. Serruys PW, Degertekin M, Tanabe K et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
21. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39:183-93.
22. Adamian M, Colombo A, Briguori C et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 2001;38:672-9.
23. Teirstein PS, Massullo V, Jani S et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting [see comments]. N Engl J Med 1997;336:1697-703.
24. Waksman R, Raizner AE, Yeung AC et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002;359:551-7.
25. Kay IP, Sabate M, Costa MA et al. Positive geometric vascular remodeling is seen after catheter-based radiation followed by conventional stent implantation but not after radioactive stent implantation. Circulation 2000;102:1434-9.
26. Teirstein PS. Living the dream of no restenosis. Circulation 2001; 104:1996-8.
27. Sabate M, Serruys PW, van der Giessen WJ et al. Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: A three-dimensional intravascular ultrasound study. Circulation 1999; 100:1182-8.
28. Konig A, Schiele TM, Rieber J et al. Stent design-related coronary artery remodeling and patterns of neointima formation following self-expanding and balloon-expandable stent implantation. Catheter Cardiovasc Interv 2002;56:478-86.
29. Serruys PW, Kay IP. I like the candy, I hate the wrapper: the (32)P radioactive stent [editorial; comment]. Circulation 2000;101:3-7.
30. van der Giessen WJ, Regar E, Harteveld MS et al. Edge Effect of 32P radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff. Circulation 2001;104:2236-41.
31. Albiero R, Nishida T, Adamian M et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 2000;101:2454-7.
32. Kornowski R, Mintz GS, Kent KM et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997;95:1366-9.
33. Shah VM, Mintz GS, Apple S et al. Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002; 106:1753-5.
34. Kobayashi Y, De Gregorio J, Kobayashi N et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-9.
35. Kastrati A, Elezi S, Dirschinger J et al. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999; 83:1617-22.
36. Degertekin M, Serruys PW, Foley DP et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002;106:1610-3.